Ryseck R - Search Results

1

Functional Antagonism of Human CD40 Achieved by Targeting a Unique Species-Specific Epitope.

Yamniuk AP, Suri A, Krystek SR, Tamura J, Ramamurthy V, Kuhn R, Carroll K, Fleener C, Ryseck R, Cheng L, An Y, Drew P, Grant S, Suchard SJ, Nadler SG, Bryson JW, Sheriff S. Yamniuk AP, et al. Among authors: ryseck r. J Mol Biol. 2016 Jul 17;428(14):2860-79. doi: 10.1016/j.jmb.2016.05.014. Epub 2016 May 21. J Mol Biol. 2016. PMID: 27216500 Free article.

2

A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor.

Emanuel SL, Engle LJ, Chao G, Zhu RR, Cao C, Lin Z, Yamniuk AP, Hosbach J, Brown J, Fitzpatrick E, Gokemeijer J, Morin P, Morse BA, Carvajal IM, Fabrizio D, Wright MC, Das Gupta R, Gosselin M, Cataldo D, Ryseck RP, Doyle ML, Wong TW, Camphausen RT, Cload ST, Marsh HN, Gottardis MM, Furfine ES. Emanuel SL, et al. Among authors: ryseck rp. MAbs. 2011 Jan-Feb;3(1):38-48. doi: 10.4161/mabs.3.1.14168. Epub 2011 Jan 1. MAbs. 2011. PMID: 21099371 Free PMC article.

3

RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.

Ryseck RP, Bull P, Takamiya M, Bours V, Siebenlist U, Dobrzanski P, Bravo R. Ryseck RP, et al. Mol Cell Biol. 1992 Feb;12(2):674-84. doi: 10.1128/mcb.12.2.674-684.1992. Mol Cell Biol. 1992. PMID: 1732739 Free PMC article.

4

Characterization of elements determining the dimerization properties of RelB and p50.

Ryseck RP, Novotny J, Bravo R. Ryseck RP, et al. Mol Cell Biol. 1995 Jun;15(6):3100-9. doi: 10.1128/MCB.15.6.3100. Mol Cell Biol. 1995. PMID: 7760806 Free PMC article.

5

Both N- and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motif.

Dobrzanski P, Ryseck RP, Bravo R. Dobrzanski P, et al. Among authors: ryseck rp. Mol Cell Biol. 1993 Mar;13(3):1572-82. doi: 10.1128/mcb.13.3.1572-1582.1993. Mol Cell Biol. 1993. PMID: 8441398 Free PMC article.

6

The product of a novel growth factor-activated gene, fic, is a biologically active "C-C"-type cytokine.

Heinrich JN, Ryseck RP, Macdonald-Bravo H, Bravo R. Heinrich JN, et al. Among authors: ryseck rp. Mol Cell Biol. 1993 Apr;13(4):2020-30. doi: 10.1128/mcb.13.4.2020-2030.1993. Mol Cell Biol. 1993. PMID: 8455595 Free PMC article.

7

Constitutively active receptor tyrosine kinases as oncogenes in preclinical models for cancer therapeutics.

Kellar KA, Lorenzi MV, Ho CP, You D, Wen ML, Ryseck RP, Oppenheimer S, Fink BE, Vite GD, Rowley BR, Yu C, Bol DK, Lee FY, Wong TW. Kellar KA, et al. Among authors: ryseck rp. Mol Cancer Ther. 2006 Jun;5(6):1571-6. doi: 10.1158/1535-7163.MCT-06-0078. Mol Cancer Ther. 2006. PMID: 16818516

8

Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein.

Ryseck RP, Macdonald-Bravo H, Mattéi MG, Bravo R. Ryseck RP, et al. Cell Growth Differ. 1991 May;2(5):225-33. Cell Growth Differ. 1991. PMID: 1888698

9

Identification of an immediate early gene, pghs-B, whose protein product has prostaglandin synthase/cyclooxygenase activity.

Ryseck RP, Raynoschek C, Macdonald-Bravo H, Dorfman K, Mattéi MG, Bravo R. Ryseck RP, et al. Cell Growth Differ. 1992 Jul;3(7):443-50. Cell Growth Differ. 1992. PMID: 1419907

10

Genetic approaches to study Rel/NF-kappa B/I kappa B function in mice.

Attar RM, Caamaño J, Carrasco D, Iotsova V, Ishikawa H, Ryseck RP, Weih F, Bravo R. Attar RM, et al. Among authors: ryseck rp. Semin Cancer Biol. 1997 Apr;8(2):93-101. doi: 10.1006/scbi.1997.0060. Semin Cancer Biol. 1997. PMID: 9299587 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page